Transforming Prostate Cancer Care: Advancing Cancer Treatment with Insights from Africa

本書深入探討前列腺癌護理的最新技術與新進展，並提供來自非洲的全新視角與見解。

本書的核心探討了幾個關鍵問題，例如前列腺癌發展的機制、早期檢測的重要性，以及診斷進展如何促成個性化治療計畫。它深入研究了基因組發現，這些發現為靶向療法鋪平了道路，並檢視了免疫療法如何重塑治療範式。此外，本書還探討了外科創新及放射性藥物在推進前列腺癌管理中的角色。討論延伸至強調整體病人福祉的整合護理模式及增強生存率的策略。本書的獨特之處在於，作者提供了來自非洲的前列腺癌流行率與管理的見解，並將其置於全球背景中。

本書旨在為參與腫瘤學及前列腺癌研究的醫療專業人員，包括醫生、護理人員及醫學研究人員，提供一份不可或缺的指南，幫助他們理解前列腺癌的基本生物學概念及其臨床治療。

In the realm of Molecular Oncology, Professor Zodwa Dlamini stands as a dedicated force, unwavering in her commitment to advancing precision oncology in Africa. At the heart of her career is the pivotal role as the Founding Director of the Pan African Cancer Research Institute (PACRI). Holding additional prestigious positions such as Director of the SAMRC Precision Oncology Research Unit (PORU) and DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Professor Dlamini demonstrates full dedication to advancing precision medicine in the ongoing battle against cancer. Beyond institutional leadership, she serves as a distinguished member of the American Association for Cancer Research (AACR) Regional Advisory Committee on Sub-Saharan Africa. In this capacity, she actively guides the AACR Pathology Resources in Africa Advisory Group, identifying strategies to address gaps in cancer pathology services across the African continent. The exceptional work in the field has earned Professor Dlamini the esteemed appointment as a distinguished Cancer Immunology Jury Member for the prestigious 2024 Innovators in Science Award. Sponsored by Takeda and administered by the New York Academy of Sciences, this accolade recognizes ground-breaking research in Cancer Immunology on a global scale. Her role on the jury affords her the privilege of providing invaluable input and guidance to the selection process, contributing a unique global perspective. Notably, Professor Dlamini is the Guest Editor and a member of the Editorial Advisory Committee (EAC) for the 2023 edition of the South African Health Review (SAHR), a special edition focusing on fortifying cancer services in South Africa. Her contributions also extend to the African Organization for Research and Training in Cancer (AORTIC), where she actively influences the organization's strategic direction and mission as a member of the Research Committee Scientific Advisory Board. The recognition of Professor Dlamini's dedication to advancing cancer research in Africa culminated in a Special Award from the Council and Executive of the African Society of Morphology, leading to her admission as an "Honorary Fellow" of the West African College of Morphologists. Moreover, she holds the esteemed titles of an Overseas Fellow of the Royal Society of Medicine (London), a Professional Member of the New York Academy of Sciences (USA), and a member of the Academy of Science of South Africa. These affiliations underscore her significant contributions to the field of Science. Through her multifaceted efforts, Professor Zodwa Dlamini remains steadfast in her commitment to shaping the ever-evolving landscape of cancer research. Her journey is driven by an unshakable belief that cancer can be conquered, paving the way for a healthier and more equitable world.

在分子腫瘤學領域，Zodwa Dlamini 教授是一位堅定的力量，對於推進非洲的精準腫瘤學始終不渝。她職業生涯的核心是擔任泛非癌症研究所（PACRI）的創始主任。Dlamini 教授還擔任南非醫學研究委員會精準腫瘤學研究單位（PORU）主任及DSI/NRF SARChI精準腫瘤學與癌症預防（POCP）主席等多個重要職位，充分展現了她在持續抗擊癌症的過程中對推進精準醫學的全心投入。除了機構領導角色外，她還是美國癌症研究協會（AACR）撒哈拉以南非洲區域諮詢委員會的傑出成員。在這個角色中，她積極指導AACR非洲病理資源諮詢小組，尋找解決非洲大陸癌症病理服務缺口的策略。她在該領域的卓越工作使她獲得了2024年科學創新獎的傑出癌症免疫學評審委員的任命，該獎項由武田贊助並由紐約科學院管理，旨在全球範圍內表彰癌症免疫學的開創性研究。她在評審委員會的角色使她能夠為選拔過程提供寶貴的意見和指導，貢獻獨特的全球視角。值得注意的是，Dlamini 教授是2023年南非健康評論（SAHR）特刊的客座編輯及編輯諮詢委員會（EAC）成員，該特刊專注於加強南非的癌症服務。她的貢獻還延伸至非洲癌症研究與培訓組織（AORTIC），在那裡她作為研究委員會科學諮詢委員會的成員，積極影響該組織的戰略方向和使命。Dlamini 教授對推進非洲癌症研究的奉獻得到了非洲形態學會理事會和執行委員會的特別獎，並使她成為西非形態學家學院的「榮譽院士」。此外，她還擁有倫敦皇家醫學會的海外院士、紐約科學院的專業會員以及南非科學院的成員等尊貴頭銜。這些隸屬關係凸顯了她對科學領域的重要貢獻。透過她多方面的努力，Zodwa Dlamini 教授始終堅持致力於塑造不斷演變的癌症研究領域。她的旅程源於堅定的信念，即癌症是可以被征服的，為創造一個更健康、更公平的世界鋪平道路。